176 related articles for article (PubMed ID: 34981569)
1. Prognostic biomarkers of cutaneous melanoma.
Ding L; Gosh A; Lee DJ; Emri G; Huss WJ; Bogner PN; Paragh G
Photodermatol Photoimmunol Photomed; 2022 Sep; 38(5):418-434. PubMed ID: 34981569
[TBL] [Abstract][Full Text] [Related]
2. Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas.
Ellis R; Tang D; Nasr B; Greenwood A; McConnell A; Anagnostou ME; Elias M; Verykiou S; Bajwa D; Ewen T; Reynolds NJ; Barrett P; Carling E; Watson G; Armstrong J; Allen AJ; Horswell S; Labus M; Lovat PE
Br J Dermatol; 2020 Jan; 182(1):156-165. PubMed ID: 31056744
[TBL] [Abstract][Full Text] [Related]
3. Melanoma biomarkers: current status and vision for the future.
Larson AR; Konat E; Alani RM
Nat Clin Pract Oncol; 2009 Feb; 6(2):105-17. PubMed ID: 19107110
[TBL] [Abstract][Full Text] [Related]
4. Revisiting determinants of prognosis in cutaneous melanoma.
Weiss SA; Hanniford D; Hernando E; Osman I
Cancer; 2015 Dec; 121(23):4108-23. PubMed ID: 26308244
[TBL] [Abstract][Full Text] [Related]
5. Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy.
Haass NK; Smalley KS
Mol Diagn Ther; 2009; 13(5):283-96. PubMed ID: 19791833
[TBL] [Abstract][Full Text] [Related]
6. Current staging and prognostic factors in melanoma.
Bartlett EK; Karakousis GC
Surg Oncol Clin N Am; 2015 Apr; 24(2):215-27. PubMed ID: 25769707
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
9. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
10. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
[TBL] [Abstract][Full Text] [Related]
11. Tissue prognostic biomarkers in primary cutaneous melanoma.
Mandalà M; Massi D
Virchows Arch; 2014 Mar; 464(3):265-81. PubMed ID: 24487785
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
13. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in young women with cutaneous melanoma.
Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in melanoma: staging, prognosis and detection of early metastases.
Carlson JA; Slominski A; Linette GP; Mihm MC; Ross JS
Expert Rev Mol Diagn; 2003 May; 3(3):303-30. PubMed ID: 12779006
[TBL] [Abstract][Full Text] [Related]
16. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
[TBL] [Abstract][Full Text] [Related]
17. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
18. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanoma of the auricle.
Mondin V; Rinaldo A; Shaha A; Cureoglu S; Devaney KO; Suárez C; Ferlito A
Acta Otolaryngol; 2005 Nov; 125(11):1140-4. PubMed ID: 16353384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]